參考文獻/References:
[1] 智信,陳曉,蘇佳燦.絕經(jīng)后骨質(zhì)疏松癥發(fā)病機制研究進展[J].中國骨質(zhì)疏松雜志,2018,24(11):1510-1513.
[2] 中華醫(yī)學會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中國骨質(zhì)疏松雜志,2019,25(3):281-309.
[3] 《中國老年骨質(zhì)疏松癥診療指南》(2018)工作組.中國老年骨質(zhì)疏松癥診療指南(2018)[J].中國骨質(zhì)疏松雜志,2018,24(12):1541-1567.
[4] 劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學概況及發(fā)病機制研究進展[J].中醫(yī)正骨,2018,30(3):52-55.
[5] 方巖,朱濤.絕經(jīng)后骨質(zhì)疏松癥的治療進展[J].中國骨質(zhì)疏松雜志,2019,25(8):1192-1200.
[6] 孫國平,羅選翔,潘彬.絕經(jīng)后骨質(zhì)疏松癥的預(yù)防和藥物聯(lián)合序貫治療[J].中國組織工程研究,2020,24(33):5385-5390.
[7] 李紹爍,顧一丹,邵陽,等.Citespace知識圖譜可視化分析中醫(yī)藥防治絕經(jīng)后骨質(zhì)疏松癥[J].中國組織工程研究,2020,24(26):4224-4230.
[8] 毛一凡,張佳鋒,陳文亮,等.從“虛瘀致毒”論骨痿骨折[J].中醫(yī)正骨,2019,31(2):44-45.
[9] 陳智能,謝麗麗,李桂錦,等.姚新苗“治痿獨取陽明”在糖尿病性骨質(zhì)疏松癥中應(yīng)用經(jīng)驗探析[J].中華中醫(yī)藥雜志,2019,34(7):3077-3080.
[10] 史曉林,梁博程,李春雯.從“因虛致瘀”論原發(fā)性骨質(zhì)疏松癥病機[J].中國中西醫(yī)結(jié)合雜志,2019,39(1):111-114.
[11] 李春雯,王均華.從虛和瘀論治骨痿[J].中醫(yī)正骨,2018,30(10):62-63.
[12] 劉震坤,金影,董克勤.董克勤治療絕經(jīng)后骨質(zhì)疏松[J].長春中醫(yī)藥大學學報,2018,34(4):702-704.
[13] 李琦,楊鶇祥,那俊夫,等.從虛從瘀探討絕經(jīng)后骨質(zhì)疏松癥疼痛發(fā)病機理[J].遼寧中醫(yī)藥大學學報,2019,21(10):162-164.
[14] 張文達,任艷玲.絕經(jīng)后骨質(zhì)疏松癥病因病機研究概況[J].遼寧中醫(yī)藥大學學報,2019,21(7):101-104.
[15] 石敏,趙繼榮,薛旭,等.基于“脾主肉、腎主骨”理論探討絕經(jīng)后骨質(zhì)疏松癥的OPG/RANK/RANKL信號調(diào)控機制[J].中國骨質(zhì)疏松雜志,2019,25(9):1336-1339.
[16] 劉淼,廖尖兵,王文譞,等.基于“治痿獨取陽明”論治特發(fā)性肺纖維化[J].中華中醫(yī)藥學刊,2018,36(6):1414-1416.
[17] 吳克亮,林曉生,肖慶華,等.從“治痿獨取陽明”論治脾腎兩虛型老年性骨質(zhì)疏松癥[J].中國骨質(zhì)疏松雜志,2020,26(3):449-453.
[18] 林鵬,金濤,史科學,等.經(jīng)皮椎體后凸成形術(shù)聯(lián)合補腎活血湯口服治療老年骨質(zhì)疏松性椎體壓縮骨折腎虛血瘀證[J].中醫(yī)正骨,2019,31(11):72-74.
[19] 秦臻,任艷玲,史馨鈺.絕經(jīng)后骨質(zhì)疏松癥的中藥用藥規(guī)律研究[J].時珍國醫(yī)國藥,2018,29(10):2531-2534.
[20] 王金鋒.益氣補腎湯治療原發(fā)性骨質(zhì)疏松癥65例臨床觀察[J].湖南中醫(yī)雜志,2020,36(2):46-47.
[21] 譚英華,熊仁青.補脾益腎方對去卵巢骨質(zhì)疏松癥模型大鼠防治作用研究[J].吉林中醫(yī)藥,2016,36(7):709-711.
[22] 王振,張曉剛,宋敏,等.OPG/RANK/RANKL系統(tǒng)與原發(fā)性骨質(zhì)疏松癥的關(guān)聯(lián)性及補腎活血法的調(diào)節(jié)作用研究進展[J].中國骨質(zhì)疏松雜志,2016,22(12):1601-1605.
[23] 楊依然,史曉林,劉鐘,等.Lc-ms法篩選強骨飲對絕經(jīng)后骨質(zhì)疏松癥患者全血差異蛋白的研究[J].中國骨質(zhì)疏松雜志,2019,25(12):1676-1679.
[24] 梁博程,李敏,王均華,等.基于系統(tǒng)生物學探討強骨飲防治原發(fā)Ⅰ型骨質(zhì)疏松癥的靶標和作用機制[J].中華全科醫(yī)學,2019,17(6):909-914.
[25] 趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(4):26-30.
[26] 趙稜,汪煌,魏杰,等.自擬強骨飲對絕經(jīng)后骨質(zhì)疏松患者血清雌激素水平及骨密度影響的臨床觀察[J].浙江中醫(yī)藥大學學報,2011,35(4):529-531.
[27] 孔令成,施振宇,姚建亮,等.強骨飲治療骨質(zhì)疏松性椎體壓縮性骨折的臨床研究[J].中國骨質(zhì)疏松雜志,2016,22(9):1159-1163.
[28] 王博,吳鵬,史曉林.強骨飲對去卵巢骨質(zhì)疏松大鼠骨顯微結(jié)構(gòu)的影響[J].中醫(yī)正骨,2016,28(7):6-9.
[29] 楊依然,劉鐘,王均華,等.強骨飲對CKIP-1過表達成骨細胞的影響研究[J].中國中醫(yī)骨傷科雜志,2018,26(10):1-5.
[30] 劉鐘,楊依然,王均華,等.益氣溫經(jīng)方對CKIP-1介導的破骨細胞凋亡的影響[J].中國中醫(yī)骨傷科雜志,2018,26(8):14-17.
相似文獻/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[3]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):19.
[6]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(09):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(09):3.
[11]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[12]歐國峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學研究進展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(09):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(09):1.
[16]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學概況及發(fā)病機制研究進展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細胞自噬的機制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(09):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(09):11.
[20]趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(09):26.